Suchergebnisse - "Cutland, Clare L"

PubPharm (120)

1

Defining and reporting adverse events of special interest in comparative maternal vaccine studies : a systematic review

enthalten in: Vaccine: X | 2024

von Davies, H. | Thorley, E. | Al-Bahadili, R. | +9

2

Obstetric and neonatal outcomes in South Africa

enthalten in: Vaccine | 2024

von Cutland, C. | Sawry, S. | Fairlie, L. | +11

3

Editorial : Vaccinations and women's reproductive health

enthalten in: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics | 2023

von Cutland, C. | Fortner, K. | Heine, R. | +1

4

Standardizing case definitions for monitoring the safety of maternal vaccines globally : GAIA definitions, a review of progress to date

enthalten in: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics | 2023

von Davies, H. | Bowman, C. | Watson, G. | +6

5

ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19

enthalten in: Nature immunology | 2023

von Kaplonek, P. | Cizmeci, D. | Kwatra, G. | +25

6

Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern : Final analysis of a randomized, placebo-controlled, phase 1b/2 study in South African adults (COV005)

enthalten in: Vaccine | 2023

von Koen, A. | Izu, A. | Baillie, V. | +33

7

Single priming and booster dose of ten-valent and 13-valent pneumococcal conjugate vaccines and Streptococcus pneumoniae colonisation in children in South Africa : a single-centre, open-label, randomised trial

enthalten in: The Lancet. Child & adolescent health | 2023

von Olwagen, C. | Izu, A. | Mutsaerts, E. | +10

CommentIn: Lancet Child Adolesc Health. 2023 May;7(5):299-301. - PMID 36934732

8

Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005) : a post-hoc analysis of a randomised, phase 1b-2a trial

enthalten in: The Lancet. Infectious diseases | 2023

von Madhi, S. | Kwatra, G. | Richardson, S. | +34

CommentIn: Lancet Infect Dis. 2023 Mar;23(3):262-263. - PMID 36273489

9

A phase 3, randomized, controlled, open-label study to evaluate the persistence up to 5 years of 1 or 2 doses of meningococcal conjugate vaccine MenACWY-TT given with or without 13-valent pneumococcal conjugate vaccine in 12-14-month-old children

enthalten in: Vaccine | 2023

von Cutland, C. | Peyrani, P. | Webber, C. | +3

10

Respiratory syncytial virus prevention within reach : the vaccine and monoclonal antibody landscape

enthalten in: The Lancet. Infectious diseases | 2023

von Mazur, N. | Terstappen, J. | Baral, R. | +38

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]